Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 4,963 | 3,263 | 3,043 | 2,092 | 4,454 |
| Operating Income | -4,963 | -3,263 | -3,043 | -2,092 | -4,454 |
| Other Income | 1,622 | -792 | 444 | -1,627 | 142 |
| Pre-tax Income | -3,341 | -4,055 | -2,599 | -3,719 | -4,312 |
| Income Tax | -724 | -889 | -208 | -446 | -289 |
| Net Income Continuous | -2,617 | -3,166 | -2,391 | -3,273 | -4,023 |
| Net Income | $-2,617 | $-3,166 | $-2,391 | $-3,273 | $-4,023 |
| EPS Basic Total Ops | -0.24 | -0.17 | -0.21 | -0.43 | -0.54 |
| EPS Basic Continuous Ops | -0.24 | -0.17 | -0.21 | -0.43 | -0.54 |
| EPS Diluted Total Ops | -0.24 | -0.17 | -0.21 | -0.43 | -0.54 |
| EPS Diluted Continuous Ops | -0.24 | -0.17 | -0.21 | -0.43 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.18 | -0.21 | -0.19 | -0.34 |
| EBITDA(a) | $-4,962 | $-3,262 | $-3,042 | $-2,090 | $-4,447 |